Trial Profile
Sugammadex Compared With Neostigmin/Atropin for Neuromuscular Block Reversal in Patients With Obstructive Sleep Apnea
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 May 2019
Price :
$35
*
At a glance
- Drugs Sugammadex (Primary) ; Atropine; Neostigmine
- Indications Sleep apnoea syndrome
- Focus Therapeutic Use
- 08 Dec 2014 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov record.
- 14 Jul 2014 New trial record